Binding a receptor is only the beginning for a therapeutic antibody or ligand; what matters next is whether the cell takes it in and where the molecule goes once inside. An internalization assay measures that next step, reporting how quickly and to what extent a candidate is taken up and how it is processed within the cell. For antibody-drug conjugates and other targeted therapies, the result is decisive: a molecule that binds well but barely enters the cell will not deliver its payload where it is needed.
An internalization service turns this into quantitative data on uptake kinetics, extent, and trafficking, so candidates can be ranked and molecular designs adjusted on evidence rather than assumption.
Two complementary formats cover both detailed single-target questions and broader screening.
Flow-based internalization assays typically return results within one to two weeks, while high-content imaging studies take slightly longer because imaging conditions and analysis must be established for the cell system. The choice follows the question: a flow readout is efficient for ranking candidates by uptake, whereas imaging adds the localization detail needed when the intracellular pathway itself is under study. Both can be applied to a pH-sensitive or a conventional fluorescent label depending on whether signal from surface-bound material must be suppressed.
A project begins with the target, the cell model, and the candidate molecules, together with the question of uptake, rate, or trafficking that must be answered. A label and detection format are selected, conditions are established so that surface binding and internalized signal can be separated, and a time course is run. Results are returned with the fitted uptake metrics and the underlying data, interpreted together rather than as isolated time points.
Internalization data are central to antibody-drug conjugate development, where payload delivery depends on uptake, and to the optimization of receptor-targeted antibodies and ligands more broadly. The assays also support mechanism studies, the comparison of formats or linkers that influence trafficking, and the selection of cell models for downstream functional work.
Each assay is run with defined controls and acceptance criteria so an uptake value is reproducible rather than assumed, and the work is performed under a documented quality system. Deliverables include the raw and analyzed data, the fitted internalization metrics, and a report covering assay design, controls, and the conclusions the data support.